End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.742 USD | -7.52% | -24.29% | -97.27% |
May. 21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
May. 20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Sunshine Biopharma, Inc.
Upcoming events on Sunshine Biopharma, Inc.
Past events on Sunshine Biopharma, Inc.
2024-05-07 | Q1 2024 Earnings Release (Projected) |
2024-04-01 03:47 pm | Q4 2023 Earnings Release |
2023-12-07 10:00 am | Annual General Meeting |
2023-11-13 08:30 am | Q3 2023 Earnings Release |
2023-10-12 10:00 am | Special Meeting of Warrant Holders |
2023-08-14 02:24 pm | Q2 2023 Earnings Release |
2023-05-10 06:28 pm | Q1 2023 Earnings Release |
2023-04-05 08:00 am | Q4 2022 Earnings Release |
2022-11-07 02:48 pm | Q3 2022 Earnings Release |
2022-08-03 05:24 pm | Interim 2022 Earnings Release |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 24,1 22,5 7.02% | 44,9 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -4,79 -4,80 0.36% | -1,04 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -4,11 -4,00 -2.89% | -0,15 |
Net income Million USD | Released Forecast Spread | -26,7 | -4,51 -4,21 -7.02% | -0,30 |
EPS USD | Released Forecast Spread | -176 | -19,0 -16,0 -18.75% | -1,00 |
Announcement Date | 04/04/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 5,56 5,00 11.22% | 5,96 6,00 -0.71% | 7,68 6,10 25.9% | 7,54 7,00 7.73% | 9,00 | 12,6 | 15,8 |
EBIT Million USD | Released Forecast Spread | -0,99 -2,14 53.68% | -0,78 -2,05 62.01% | -1,19 -1,20 1.42% | -1,35 -1,29 -4.45% | -0,79 | 0,05 | 1,05 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,81 -1,87 56.37% | -0,61 -1,73 64.75% | -1,03 -0,91 -12.63% | -1,26 -1,01 -24.53% | -0,52 | 0,32 | 1,31 |
Net income Million USD | Released Forecast Spread | -0,90 -1,87 51.67% | -0,65 -1,75 62.81% | -1,25 -0,95 -30.99% | -1,28 -1,05 -21.92% | -0,56 | 0,28 | 1,27 |
EPS USD | Released Forecast Spread | -2,00 -8,00 75% | -4,00 -6,00 33.33% | -5,70 -3,00 -90% | -2,00 -1,04 -92.31% | -3,00 | 2,00 | 7,00 |
Announcement Date | 10/08/23 | 13/11/23 | 28/03/24 | 20/05/24 | - | - | - |
Past sector events for Sunshine Biopharma, Inc.
Today | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
2024-05-26 | CSPC PHARMACEUTICAL GROUP LTD.: Q1 2024 Earnings Release |
2024-05-26 | NATCO PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-24 | BLUE JET HEALTHCARE LIMITED: Q4 2024 Earnings Release |
2024-05-24 | AUROBINDO PHARMA: Q4 2024 Earnings Release |
2024-05-24 | DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-24 10:56 am | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release |
2024-05-24 08:18 am | TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-23 10:47 am | ORCHID PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-23 06:45 am | SHILPA MEDICARE LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SBFM Stock
- Calendar Sunshine Biopharma, Inc.